Cannabics Pharmaceuticals Stock Current Valuation
| CNBX Stock | USD 0.01 0 24.00% |
Valuation analysis of Cannabics Pharmaceuticals helps investors to measure Cannabics Pharmaceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Cannabics Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Cannabics Pharmaceuticals is based on 3 months time horizon. Increasing Cannabics Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cannabics Pharmaceuticals is useful when determining the fair value of the Cannabics otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cannabics Pharmaceuticals. Since Cannabics Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cannabics OTC Stock. However, Cannabics Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0124 | Real 0.0096 | Hype 0.01 |
The real value of Cannabics OTC Stock, also known as its intrinsic value, is the underlying worth of Cannabics Pharmaceuticals OTC Stock, which is reflected in its stock price. It is based on Cannabics Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Cannabics Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cannabics Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cannabics Pharmaceuticals helps investors to forecast how Cannabics otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cannabics Pharmaceuticals more accurately as focusing exclusively on Cannabics Pharmaceuticals' fundamentals will not take into account other important factors: Cannabics Pharmaceuticals OTC Stock Current Valuation Analysis
Cannabics Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Cannabics Pharmaceuticals Current Valuation | 6.67 M |
Most of Cannabics Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabics Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Cannabics Pharmaceuticals has a Current Valuation of 6.67 M. This is 99.95% lower than that of the Pharmaceuticals sector and 99.86% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.96% higher than that of the company.
Cannabics Pharmaceuticals is the top company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 4.76 Billion. Cannabics Pharmaceuticals adds roughly 6.67 Million in current valuation claiming only tiny portion of equities under Health Care industry.Cannabics Fundamentals
| Return On Equity | -42.89 | |||
| Return On Asset | -1.0 | |||
| Current Valuation | 6.67 M | |||
| Shares Outstanding | 1.26 M | |||
| Shares Owned By Insiders | 57.59 % | |||
| Price To Earning | 31.09 X | |||
| Price To Book | 20.39 X | |||
| Price To Sales | 7,566 X | |||
| Gross Profit | 7.16 K | |||
| EBITDA | (3.52 M) | |||
| Net Income | (3.72 M) | |||
| Cash And Equivalents | 96.28 K | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 1.6 M | |||
| Debt To Equity | 0.48 % | |||
| Current Ratio | 0.11 X | |||
| Book Value Per Share | (1.57) X | |||
| Cash Flow From Operations | (1.68 M) | |||
| Earnings Per Share | (3.80) X | |||
| Beta | 1.52 | |||
| Market Capitalization | 123.28 K | |||
| Total Asset | 811.17 K | |||
| Z Score | -13.2 | |||
| Net Asset | 811.17 K |
About Cannabics Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannabics Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabics Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabics Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cannabics Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cannabics Pharmaceuticals' short interest history, or implied volatility extrapolated from Cannabics Pharmaceuticals options trading.
Pair Trading with Cannabics Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cannabics Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabics Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cannabics Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cannabics Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cannabics Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cannabics Pharmaceuticals to buy it.
The correlation of Cannabics Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cannabics Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cannabics Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cannabics Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cannabics Pharmaceuticals. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Cannabics Pharmaceuticals information on this page should be used as a complementary analysis to other Cannabics Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Cannabics OTC Stock analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |